Estenose esofágica adquirida: relato de caso / Esophageal stenosis acquired: case report / Estenosis esofágica adquirida: informe de un caso

Refluxos gastroesofágicos podem ocorrer por diversos fatores como fármacos anestésicos, pré-disposição de raça, ausência de jejum, idade e sexo. A exposição da mucosa esofágica ao conteúdo gástrico é a principal causa de esofagites, que, por sua vez, podem evoluir para uma estenose do órgão, formando uma faixa circular intraluminal, causando estreitamento e comprometendo o lúmen esofágico. O presente trabalho tem por objetivo descrever um caso de estenose esofágica decorrente de ovariohisterectomia, dando ênfase às possíveis causas, formas de diagnóstico, tratamento e profilaxia da enfermidade. A cadela relatada foi atendida no setor de Clínica Médica de Animais de Companhia do Hospital Veterinário da UFVJM, Campus Unaí no dia 14 de novembro de 2019, aproximadamente um mês após receber o diagnóstico de estenose esofágica, obtido pelo histórico, sinais clínicos, achados radiográficos e, principalmente, por endoscopia esofágica. De acordo com dados da literatura, o animal apresentava diversos fatores que pré-dispõem ao refluxo gastroesofágico e, consequentemente, a estenose esofágica, como o histórico cirúrgico, idade e raça, dentre outros. Receitou-se tratamento clínico com antiácidos e inibidores da bomba de prótons para remissão clínica.

Gastroesophageal reflux may occur during anesthesia due to various factors such as anesthetic drugs, race disposition, absence of fasting, age and gender. Exposure of the esophageal mucosa to gastric contents is the main cause of esophagitis, which in turn may develop into esophageal stricture, forming an intraluminal circular band, causing narrowing and compromising the esophageal lumen. The objective of this work is to describe a case of esophageal stricture resulting from an ovariohysterectomy, emphasizing the possible causes, diagnosis, treatment and prophylaxis of the disease. The bitch of this report was attended of the group of Small Animals Medical Clinic II of UFVJM-Campus Unaí together with the teacher responsible for the discipline attended the reported animal on November 14, 2019, approximately one month of receiving diagnosis of esophageal etricture, obtained through history, signs radiographic findings and mainly by esophageal endoscopy. According to data from the literature, the animal had several factors that predispose to gastroesophageal reflux and consequently sophageal stricture, such as surgical history, age, race and others. Clinical treatment with antacids and proton pump inhibitors was prescribed for clinical remission.

Los reflujos gastroesofágicos pueden producirse durante la anestesia debido a varios factores como los fármacos anestésicos, la predisposición de la raza, la ausencia de ayuno, la edad y el sexo. La exposición de la mucosa esofágica al contenido gástrico es la principal causa de la esofagitis, que a su vez puede evolucionar hacia una estenosis esofágica, formando una banda circular intraluminal, provocando un estrechamiento y comprometiendo la luz esofágica.El presente trabajo tiene como objetivo describir un caso de estenosis esofágica resultante de una ovariohisterectomía, destacando las posibles causas, formas de diagnóstico, tratamiento y profilaxis de la enfermedad. La perra relatada fue atendida en el sector de Clínica Médica de Animales de Compañía del Hospital Veterinario de la UFVJM, Campus Unaí junto con el profesor responsable del sujeto el 14 de noviembre de 2019, aproximadamente un mes después de recibir el diagnóstico de estenosis esofágica, obtenido a través de la historia, los signos clínicos, los hallazgos radiográficos y principalmente por la endoscopia esofágica.De acuerdo con los datos de la literatura, el animal presentaba varios factores que predisponen al reflujo gastroesofágico y consecuentemente a la estenosis esofágica, como los antecedentes quirúrgicos, la edad, la raza entre otros. Se prescribió un tratamiento clínico con antiácidos e inhibidores de la bomba de protones para la remisión clínica.

Efeitos cardiorrespiratórios da dexmedetomidina isolada e associada à morfina na medicação pré-anestésica de cadelas submetidas à ovariohisterectomia eletiva / Cardiorespiratory effects of dexmedetomidine alone and associated to morphine as premedicants in healthy bitches undergoing ovariohisterectomy / Efectos cardiorespiratorios de la dexmedetomidina aislada y asociada con morfina sobre medicamentos pre-anestésicos de perras sometidas a ovariohisterectomía electiva

Objetivou-se avaliar os efeitos cardiorrespiratórios da dexmedetomidina isolada e associada à morfina em pacientes submetidas à anestesia geral inalatória com isoflurano e submetidas à ovariohisterectomia eletiva. Vinte cadelas saudáveis foram selecionadas a partir de exames físico e laboratoriais. Os animais foram distribuídos aleatoriamente em dois grupos: dexmedetomidina (10 µg/Kg) (GD) e dexmedetomidina (10 µg/Kg) associado com morfina 0,3 mg/Kg (GDM), administrados pela via intramuscular (IM). Ato contínuo, o paciente foi induzido com propofol (à efeito) e mantido com isoflurano diluído em oxigênio 100% e administrado através de vaporizador calibrado. Foram aferidos os parâmetros fisiológicos: frequências cardíaca (FC) e respiratória (f), temperatura corporal (T°C), pressões arteriais sistólica (PAS), diastólica (PAD) e média (PAM), saturação de oxigênio na hemoglobina (SpO2), pressão parcial de gás carbônico no final da expiração (ETCO2) e isoflurano expirado (ETISO). A hemogasometria arterial foi utilizada para a análise do potencial hidrogeniônico (pH), bicarbonato (HCO3-) e pressão parcial de dióxido de carbono (PaCO2). O procedimento cirúrgico teve duração máxima de 45 minutos. Os parâmetros demonstraram diferença estatística entre os tempos e grupos avaliados, de acordo com os testes de Tukey e Bonferroni (p<0,05). Observou-se bradicardia 30 minutos após a aplicação da medicação pré-anestésica e acidemia no período trans-anestésico. Apesar disto, tanto a dexmedetomidina isolada quanto associada, conferiram estabilidade hemodinâmica e respiratória, apesar da bradicardia e acidemia observada.(AU)

This study aimed to evaluate the cardiorespiratory effects of dexmedetomidine alone and associated with morphine. Twenty healthy dogs were selected from physical and laboratory exams. The animals were randomly distributed into two groups: 10 µg/Kg dexmedetomidine (DG) and 10 µg/Kg dexmedetomidine group associated with 0.3 mg/Kg morphine (GDM), administered intramuscularly (IM). The patients were induced with propofol (to effect) and maintained with isoflurane diluted in 100% oxygen and administered through a calibrated vaporizer. Physiological parameters were measured: heart rate (HR), respiratory rate (f), body temperature (T°C), systolic arterial pressure (SAP), diastolic arterial pressure (DAP) and mean arterial pressure (MAP), oxygen saturation of hemoglobin (SpO2), end-tidal carbon dioxide partial pressure (ETCO2) and end-tidal isoflurane concentration (ETISO). Arterial blood gas analysis was used to analyze hydrogen potential (pH), bicarbonate (HCO3-) and partial pressure of carbon dioxide (PaCO2). The surgical procedure lasted up to 45 minutes. The parameters showed a statistical difference between the times and groups evaluated, according to the Tukey and Bonferroni tests (p<0.05). Bradycardia was observed 30 minutes after the application of pre-anesthesic medication and acidemia in the trans-anesthetic period. Despite this, both dexmedetomidine alone and associated, provided good hemodynamic and respiratory stability, despite the bradycardia and acidemia observed.(AU)

Este estudio tuvo como objetivo evaluar los efectos cardiorrespiratorios de la dexmedetomidina sola y asociada con la morfina en pacientes sometidas a anestesia general por inhalación con isoflurano y sometidas a ovariohisterectomía electiva. Se seleccionaron veinte perras sanas a partir de exámenes físicos y de laboratorio. Los animales se dividieron aleatoriamente en dos grupos: dexmedetomidina (10 µg/kg) (GD) y dexmedetomidina (10 µg/kg) asociada con 0,3 mg/kg de morfina (GDM), administrada por vía intramuscular (IM). Posteriormente, el paciente fue inducido con propofol (en efecto) y mantenido con isoflurano diluido en oxígeno al 100% y administrado mediante de un vaporizador calibrado. Se midieron parámetros fisiológicos: frecuencia cardíaca (FC) y respiratoria (f), temperatura corporal (T°C), presión arterial sistólica (PAS), diastólica (PAD) y media (PAM), saturación de oxígeno de hemoglobina (SpO2), presión parcial de carbono dióxido al final de la expiración (ETCO2) e isoflurano expirado (ETISO). Se utilizó gasometría arterial para analizar el potencial de hidrógeno (pH), el bicarbonato (HCO3-) y la presión parcial de dióxido de carbono (PaCO2). El procedimiento quirúrgico tuvo una duración máxima de 45 minutos. Los parámetros mostraron diferencia estadística entre los tiempos y grupos evaluados, según las pruebas de Tukey y Bonferroni (p <0.05). Se observó bradicardia 30 minutos después de la aplicación de medicación preanestésica y acidemia en el período transnestésico. A pesar de esto, tanto la dexmedetomidina aislada como la asociada proporcionaron estabilidad hemodinámica y respiratoria, a pesar de la bradicardia y acidemia observadas.(AU)

Effects on the lipid peroxidation and the antioxidant defense systems of the use of isoflurane or sevoflurane in calves undergoing surgery

Background: Incoming anaesthesia created by the use of many drugs with different physicochemical properties is a sourceof stress and trauma for the body. This event increases the oxidative response and changes the balance between oxidant/antioxidant capacity in the organism in favor of oxidant capacity. This situation is defined as oxidative stress. For thesereasons, studies are conducted to determine the effects of general anaesthetic agents on oxidant and antioxidant systems inthe organism. In this study, it was aimed to determine the effects of isoflurane and sevoflurane used for general anaesthesiain humans and animals on lipid peroxidation and antioxidant defense system in calves.Materials, Methods & Results: The study included 14 calves of different breeds, ages, sexes, and weighing, average 2 weeksold. The cases randomly were divided into 2 groups, the isoflurane group (group I), and the sevoflurane group (group II),and each group included 7 animals. Before general anaesthesia, 0.04 mg/kg atropine was administered intramuscularly toall animals for premedication. At 15 min after atropine administration, isoflurane was administered at an inspiratory concentration of 3-5% in group I, and sevoflurane was administered at an inspiratory concentration of 5-7% in group II, via aface mask for 15 min for the induction of anaesthesia. Endotracheal intubation was performed in all cases at the 15 min ofthe induction period following the onset of general anaesthesia symptoms. After the induction, anaesthesia was continuedat an inspiratory concentration of 1.5-3% in the isoflurane group and inspiratory concentration of 2.5-4% in the sevofluranegroup. Blood samples were taken just before anaesthesia, just before skin incision, at the end of anaesthesia and surgery,and at the 24 h postoperatively. The malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione...

Effects on the lipid peroxidation and the antioxidant defense systems of the use of isoflurane or sevoflurane in calves undergoing surgery

Background: Incoming anaesthesia created by the use of many drugs with different physicochemical properties is a sourceof stress and trauma for the body. This event increases the oxidative response and changes the balance between oxidant/antioxidant capacity in the organism in favor of oxidant capacity. This situation is defined as oxidative stress. For thesereasons, studies are conducted to determine the effects of general anaesthetic agents on oxidant and antioxidant systems inthe organism. In this study, it was aimed to determine the effects of isoflurane and sevoflurane used for general anaesthesiain humans and animals on lipid peroxidation and antioxidant defense system in calves.Materials, Methods & Results: The study included 14 calves of different breeds, ages, sexes, and weighing, average 2 weeksold. The cases randomly were divided into 2 groups, the isoflurane group (group I), and the sevoflurane group (group II),and each group included 7 animals. Before general anaesthesia, 0.04 mg/kg atropine was administered intramuscularly toall animals for premedication. At 15 min after atropine administration, isoflurane was administered at an inspiratory concentration of 3-5% in group I, and sevoflurane was administered at an inspiratory concentration of 5-7% in group II, via aface mask for 15 min for the induction of anaesthesia. Endotracheal intubation was performed in all cases at the 15 min ofthe induction period following the onset of general anaesthesia symptoms. After the induction, anaesthesia was continuedat an inspiratory concentration of 1.5-3% in the isoflurane group and inspiratory concentration of 2.5-4% in the sevofluranegroup. Blood samples were taken just before anaesthesia, just before skin incision, at the end of anaesthesia and surgery,and at the 24 h postoperatively. The malondialdehyde (MDA), superoxide dismutase (SOD), catalase (CAT), glutathione...(AU)

Anesthesia of tambaqui Colossoma macropomum (Characiformes: Serrasalmidae) with the essential oils of Aniba rosaeodora and Aniba parviflora and their major compound, linalool

The aim of this study was to determine the anesthetic efficacy of the essential oils (EOs) of Aniba rosaeodora (EOAR) and Aniba parviflora (EOAP) and one of their main compounds, linalool, in two forms: synthetic and extracted from EOAR (linalool-AR) in tambaqui (Colossoma macropomum). In the first experiment, the anesthetic induction and recovery of juveniles exposed to 25- 200 µL L-1 of EOAR or 50- 300 µL L-1 of EOAP or synthetic linalool or linalool-AR was evaluated. The second experiment observed the behavioral effects of long-term exposure (12h) of these EOs and linalools (5 and 10 µL L-1). Fish exposed to 50-200 µL L-1 of EOAR and 100-300 µL L-1 of EOAP and both linalools reached deep anesthesia between 1-10 min. Induction time for all anesthesia stages decreased with the increasing concentration of the anesthetics. Linalool-AR showed lengthier time for anesthesia induction in some stages and for recovery at 100 and 200 µL L-1 in comparison to synthetic linalool. Normal equilibrium and swimming behavior was observed in fish exposed to the EOs and linalools throughout the 12 h of exposure. In conclusion, both EOs and linalools can be used as anesthetics and sedatives in tambaqui.(AU)

O objetivo deste trabalho foi determinar a eficácia anestésica dos óleos essenciais (OEs) de Aniba rosaeodora (OEAR) Aniba parviflora (OEAP) e um de seus compostos majoritários, linalol, em duas formas: sintética e extraída a partir de OEAR (linalol-AR) em tambaqui (Colossoma macropomum). No primeiro experimento avaliou-se a indução anestésica e a recuperação de juvenis expostos a 25- 200 µL L-1 de EOAR ou 50- 300 µL L-1 de EOAP ou linalol sintético ou linalol-AR. No segundo experimento observaram-se os efeitos comportamentais de uma longa exposição (12h) a estes OEs e linalois (5 e 10 µL L-1). Os peixes expostos a 50-200 µL L-1 de EOAR e 100-300 µL L-1 de OEAP e ambos os linalois alcançaram anestesia profunda entre 1-10 min. Tempo de indução a todos os estágios de anestesia diminuiu com o aumento na concentração dos anestésicos. Linalol-AR levou um maior tempo para induzir anestesia e para recuperação com 100 e 200 µL L-1 em comparação ao composto sintético. Peixes expostos aos OES e linalois por 12 h apresentaram equilíbrio e comportamento natatório normais. Em conclusão, tanto os OEs como o linalol sintético ou natural de AR podem ser usados como anestésicos e sedativos em tambaqui.(AU)

Anesthesia of tambaqui Colossoma macropomum (Characiformes: Serrasalmidae) with the essential oils of Aniba rosaeodora and Aniba parviflora and their major compound, linalool

The aim of this study was to determine the anesthetic efficacy of the essential oils (EOs) of Aniba rosaeodora (EOAR) and Aniba parviflora (EOAP) and one of their main compounds, linalool, in two forms: synthetic and extracted from EOAR (linalool-AR) in tambaqui (Colossoma macropomum). In the first experiment, the anesthetic induction and recovery of juveniles exposed to 25- 200 µL L-1 of EOAR or 50- 300 µL L-1 of EOAP or synthetic linalool or linalool-AR was evaluated. The second experiment observed the behavioral effects of long-term exposure (12h) of these EOs and linalools (5 and 10 µL L-1). Fish exposed to 50-200 µL L-1 of EOAR and 100-300 µL L-1 of EOAP and both linalools reached deep anesthesia between 1-10 min. Induction time for all anesthesia stages decreased with the increasing concentration of the anesthetics. Linalool-AR showed lengthier time for anesthesia induction in some stages and for recovery at 100 and 200 µL L-1 in comparison to synthetic linalool. Normal equilibrium and swimming behavior was observed in fish exposed to the EOs and linalools throughout the 12 h of exposure. In conclusion, both EOs and linalools can be used as anesthetics and sedatives in tambaqui.(AU)

O objetivo deste trabalho foi determinar a eficácia anestésica dos óleos essenciais (OEs) de Aniba rosaeodora (OEAR) Aniba parviflora (OEAP) e um de seus compostos majoritários, linalol, em duas formas: sintética e extraída a partir de OEAR (linalol-AR) em tambaqui (Colossoma macropomum). No primeiro experimento avaliou-se a indução anestésica e a recuperação de juvenis expostos a 25- 200 µL L-1 de EOAR ou 50- 300 µL L-1 de EOAP ou linalol sintético ou linalol-AR. No segundo experimento observaram-se os efeitos comportamentais de uma longa exposição (12h) a estes OEs e linalois (5 e 10 µL L-1). Os peixes expostos a 50-200 µL L-1 de EOAR e 100-300 µL L-1 de OEAP e ambos os linalois alcançaram anestesia profunda entre 1-10 min. Tempo de indução a todos os estágios de anestesia diminuiu com o aumento na concentração dos anestésicos. Linalol-AR levou um maior tempo para induzir anestesia e para recuperação com 100 e 200 µL L-1 em comparação ao composto sintético. Peixes expostos aos OES e linalois por 12 h apresentaram equilíbrio e comportamento natatório normais. Em conclusão, tanto os OEs como o linalol sintético ou natural de AR podem ser usados como anestésicos e sedativos em tambaqui.(AU)

Pathological findings of post-anesthetic myopathy associated with type 1 polysaccharide storage myopathy in a percheron horse

Background: Post-anesthetic myopathy is the most common complication associated with general anesthesia in horses. Polysaccharide storage myopathy (PSSM) is characterized by an abnormal accumulation of glycogen and glycogen-related polysaccharides in the skeletal muscle, which is categorized in type 1 (PSSM1) and type 2 (PSSM2). The purpose of this study is to report the clinical, pathological and molecular findings in a Percheron mare with post-anesthetic myopathy associated with a PSSM1. Case: A 9-year-old Percheron mare was submitted to a caesarean section due to clinical dystocia during labor. Xylazine was employed during pre-anesthesia, followed by induction with ketamine and diazepam, while anesthetic maintenance was obtained with isoflurane. The mare showed good recovery, however 24 h later, sternal recumbency and hyperthermia (41° C) were observed. The mare was euthanized, and a necropsy was performed. Samples of multiple tissues were collected and routinely processed for histology. At necropsy, segments of skeletal muscles had bilateral pale areas. The kidneys had old and recent infarcts. The heart had whitish areas in the myocardium. The brain showed focally extensive reddish areas, with flattening of gyri. Histologically, skeletal muscle fibers had in the sarcoplasm multiple homogeneous globular clear eosinophilic formations, in addition to mild hyaline necrosis. In the heart and in the kidney, there were extensive areas of acute coagulative necrosis. The brain showed marked multifocal fibrinoid degeneration of vessels and hemorrhage. Refrigerated liver samples were submitted to DNA extraction to detect mutations in the GYS1 (type 1 PSSM) and RyR1 genes (malignant hyperthermia). A positive result for a homozygous dominant mutation in GYS1 (type 1 PSSM) was observed, while the mutation responsible for malignant hyperthermia was not identified.[...]

Pathological findings of post-anesthetic myopathy associated with type 1 polysaccharide storage myopathy in a percheron horse

Background: Post-anesthetic myopathy is the most common complication associated with general anesthesia in horses. Polysaccharide storage myopathy (PSSM) is characterized by an abnormal accumulation of glycogen and glycogen-related polysaccharides in the skeletal muscle, which is categorized in type 1 (PSSM1) and type 2 (PSSM2). The purpose of this study is to report the clinical, pathological and molecular findings in a Percheron mare with post-anesthetic myopathy associated with a PSSM1. Case: A 9-year-old Percheron mare was submitted to a caesarean section due to clinical dystocia during labor. Xylazine was employed during pre-anesthesia, followed by induction with ketamine and diazepam, while anesthetic maintenance was obtained with isoflurane. The mare showed good recovery, however 24 h later, sternal recumbency and hyperthermia (41° C) were observed. The mare was euthanized, and a necropsy was performed. Samples of multiple tissues were collected and routinely processed for histology. At necropsy, segments of skeletal muscles had bilateral pale areas. The kidneys had old and recent infarcts. The heart had whitish areas in the myocardium. The brain showed focally extensive reddish areas, with flattening of gyri. Histologically, skeletal muscle fibers had in the sarcoplasm multiple homogeneous globular clear eosinophilic formations, in addition to mild hyaline necrosis. In the heart and in the kidney, there were extensive areas of acute coagulative necrosis. The brain showed marked multifocal fibrinoid degeneration of vessels and hemorrhage. Refrigerated liver samples were submitted to DNA extraction to detect mutations in the GYS1 (type 1 PSSM) and RyR1 genes (malignant hyperthermia). A positive result for a homozygous dominant mutation in GYS1 (type 1 PSSM) was observed, while the mutation responsible for malignant hyperthermia was not identified.[...](AU)

A comparasion of laboratory and cardiopulmonary effects of desflurane, detomidine and medetomidine anaesthetic combinations in horses

Background: Equine anesthesia morbidity and mortality rates are greater than in other domestic animals because of hypotension and hypoventilation. The important features desired in general anesthesia for horses are a rapid effect, rapid emergence and balanced anesthesia. The long duration of action of currently used anesthetic agents cause various complications in horses. The aim of the present study was to compare the clinical effects of combination of the anesthetics desflurane, detomidine and medetomidine in horses.Materials, Methods & Results: Eight healthy mixed-breed horses (four males and four females) with weighing 275 ± 56 kg [mean ± standard deviation (SD)] and aged 6.8 ± 5 years [(mean ± SD)] were used for this study. The horses were placed into one of four groups: group I (detomidine-desflurane), group II (detomidine-desflurane-atipamezole), group III (medetomidine- desflurane), or group IV (medetomidine-desflurane-atipamezole). Horses were rested for 15 days before each group starts to study. Intravenous detomidine (25 μg/kg) was used for premedication in groups I and II, and intravenous medetomidine (7 μg/kg) was used for premedication in groups III and IV. Ketamine hydrocholoride (2 mg/kg) and midazolam (0.03 mg/kg) were intravenously administered in the same syringe to induce anesthesia. After induction of anesthesia, horses were placed in the left lateral recumbent position, and the trachea was intubated with a cuffed endotracheal tube with an internal diameter of 28 mm. The endotracheal tube was attached to a large animal circle breathing system anesthesia machine, and anesthesia was maintained with desflurane for 90 min. The initial dosage of desflurane was 14% + 4 L O2/min, and was reduced by 2% every 10 min over the first 30 min of anesthesia. After 30 min, the desflurane dose was changed to 8% + 4 L, which was maintained until the end of anesthesia (90 min).[...]

A comparasion of laboratory and cardiopulmonary effects of desflurane, detomidine and medetomidine anaesthetic combinations in horses

Background: Equine anesthesia morbidity and mortality rates are greater than in other domestic animals because of hypotension and hypoventilation. The important features desired in general anesthesia for horses are a rapid effect, rapid emergence and balanced anesthesia. The long duration of action of currently used anesthetic agents cause various complications in horses. The aim of the present study was to compare the clinical effects of combination of the anesthetics desflurane, detomidine and medetomidine in horses.Materials, Methods & Results: Eight healthy mixed-breed horses (four males and four females) with weighing 275 ± 56 kg [mean ± standard deviation (SD)] and aged 6.8 ± 5 years [(mean ± SD)] were used for this study. The horses were placed into one of four groups: group I (detomidine-desflurane), group II (detomidine-desflurane-atipamezole), group III (medetomidine- desflurane), or group IV (medetomidine-desflurane-atipamezole). Horses were rested for 15 days before each group starts to study. Intravenous detomidine (25 μg/kg) was used for premedication in groups I and II, and intravenous medetomidine (7 μg/kg) was used for premedication in groups III and IV. Ketamine hydrocholoride (2 mg/kg) and midazolam (0.03 mg/kg) were intravenously administered in the same syringe to induce anesthesia. After induction of anesthesia, horses were placed in the left lateral recumbent position, and the trachea was intubated with a cuffed endotracheal tube with an internal diameter of 28 mm. The endotracheal tube was attached to a large animal circle breathing system anesthesia machine, and anesthesia was maintained with desflurane for 90 min. The initial dosage of desflurane was 14% + 4 L O2/min, and was reduced by 2% every 10 min over the first 30 min of anesthesia. After 30 min, the desflurane dose was changed to 8% + 4 L, which was maintained until the end of anesthesia (90 min).[...](AU)

Tempo de indução e recuperação à anestesia do eugenol para patinga (Piaractus brachypomus) / Eugenol anesthesia induction and recovery time for (Piaractus brachypomus) / Tiempo de inducción y recuperación a la anestesia de eugenol en morocoto (Piaractus brachypomus)

Este trabalho tem como finalidade avaliar o uso do eugenol como anestésico para a patinga (Piaractus brachypomus), mensurando o tempo de indução à anestesia e recuperação. Foram mensurados o tempo de indução e recuperação à anestesia em diferentes concentrações de eugenol e glicose plasmática. Os resultados foram analisados segundo um delineamento inteiramente casualisado (DIC) com seis tratamentos (controle, 25, 35, 50, 75 e 150 L-1 de eugenol) e dez repeti- ções cada. As análises de variância (ANOVA) e as médias foram comparadas pelo teste de Tukey. Concentrações acima de 150mg.L-¹ apresentaram mortalidade de 100% da população. Os tempos de indução à anestesia profunda registrada para as concentrações de 50 e 75mg L-1 foram que apresentaram menores tempos de sedação. Observa-se que o tempo de recuperação patinganas doses de 50mg.L-¹ foi de 93 seg. a dose de 25mg.L-1 de eugenol foi a única que obteve diminuição nos níveis de glicose plasmática, o que pode ser um indício de utilização de pequenas doses deste no manejo da patinga. Conclui-se que o eugenol é um anestésico adequado para juvenis patinga com peso de 256,6±73,18g. Podendo utilizado em concentrações de 50mg. L-1 de eugenol.(AU)

This paper aims to standardize the use of eugenol as an anesthetic for the patinga (Piaractus brachypomus), measuring the time for anesthesia induction and recovery. Induction and recovery times to anesthesia were measured in different concentrations of eugenol and plasma glucose. The results were analyzed according to a completely randomized design (CRD) with six treatments (control, 25, 35, 50, 75 and 150 L-1 of eugenol) and ten repetitions each. The analysis of variance (ANOVA) and averages were compared by Tukey test. Concentrations above 150 mg.L-¹ presented 100% mortality of the population. The deep anesthesia induction times recorded for concentrations of 50 and 75 mg L-1 were the ones presenting the shortest sedation times. It can be observed that the patinga recovery time for 50mg.L-1 doses was 93 seconds. The 25mg.L-1 dose of eugenol was the only dose obtaining a decrease in plasma glucose levels which can be an indication to the use of small doses for the management of patinga. It can also be concluded that eugenol is a suitable anesthetic for patinga weighing 256.6 ± 73.18 g, and it can be used at concentrations of 50mg. L-1 eugenol.(AU)

Este estudio ha tenido como objetivo evaluar el uso de eugenol como anestésico para el morocoto Piaractus brachypomus, midiendo el tiempo de inducción a la anestesia y recuperación. Fueron medidos el tiempo de inducción y recuperación a la anestesia en diferentes concentraciones de eugenol y la glucosa plasmática. Los resultados fueron analizados según un delineamiento enteramente casualizado con seis tratamientos (control, 25, 35, 50, 75 y 150 L-1 de eugenol) y 10 (diez) repeticiones cada uno. El análisis de varianza (ANOVA) y los promedios se compararon por prueba Tukey. Concentraciones superiores a 150 mg.L-¹ presentaron mortalidad de 100% de la población. Los tiempos de inducción a la anestesia profunda registrada para las concentraciones de 50 y 75 mg L-1 fueron las que presentaron menores tiempos de sedación. Se observa que el tiempo de recuperación de morocotos con dosis de 50 mg.L-1 fue de 93 seg. La dosis de 25 mg.L-1 de eugenol fue la única que obtuvo disminución en los niveles de glucosa plasmática, lo que puede ser un indicio de utilización de dosis pequeñas de esto en manejos de morocotos. Se concluye que el eugenol es un anestésico adecuado para morocotos juveniles con peso de 256.6 ± 73, 18 g, pudiendo ser utilizado en concentraciones de 50 mg. L-1 de eugenol.(AU)

Efeitos anestésicos da administração intranasal ou intramuscular de cetamina S+ e midazolam em pomba-rola (Streptotelia sp) / Anesthetic effects of intranasal or intramuscular administration of S+ Ketamine and Midazolam in ring necked dove (Streptotelia sp)

A via intranasal é uma boa alternativa por ser indolor e de fácil aplicação em aves. O objetivo deste estudo foi avaliar os efeitos anestésicos da associação de cetamina S+ e midazolam pela via intranasal (IN) em comparação com a via intramuscular (IM) em pombos. Foram utilizados 12 pombos alocados em dois grupos com 15 dias de intervalo, os quais receberam: grupo IM: 20 mg/kg de cetamina S+ associada a 3,5 mg/kg de midazolam pela via intramuscular (musculatura do peito); e grupo IN, mesmo protocolo, porém, pela via intranasal. Os parâmetros avaliados foram: período de latência, tempo de duração em decúbito dorsal, tempo total de anestesia, tempo de recuperação e efeitos adversos. Para a análise estatística, empregou-se o teste de Wilcoxon, com as diferenças consideradas significativas quando P<0,05. O período de latência obtido foi de 30 [30-47,5] e 40 [30-50] segundos para IM e IN, respectivamente. O tempo de duração de decúbito dorsal foi de 59 [53,25-65] e 63 [37-71,25] minutos para IM e IN, respectivamente, sem diferenças significativas entre os grupos. Com relação à duração total de anestesia, foi observada diferença significativa, com 88 [86,25-94,5] e 68 [53,5-93] minutos para os grupos IM e IN, respectivamente. O tempo de recuperação foi mais curto no grupo IN (15 [4,25-19,5]) comparado ao IM (32 [28,25-38,25] minutos). Dois animais de cada grupo apresentaram regurgitação na fase de recuperação. Conclui-se que a administração de cetamina S+ e midazolam pela via intranasal é um método aceitável de administração de fármacos e produz anestesia rápida e eficaz em pombos.(AU)

The intranasal route is a good alternative because is painless and easy to perform in birds. The objective of this study was to evaluate the anesthetic effects of S+ ketamine and midazolam administered by intranasal or intramuscular route in pigeons. Twelve animals were used in a randomized and crossover design. Animals received two treatments with 2-weeks interval. IM group: animals received 20mg/kg of S+ ketamine and 3.5mg/kg of midazolam by intramuscular route (pectoral muscles); IN group: animals received the same protocol by intranasal route. Parameters evaluated were: onset of action, time of duration in dorsal recumbency; total time of anesthesia and side effects. Statistical analysis was performed using Wilcoxon test and the differences were considered significant when P<0.05. Onset of action was 30 [30-47.5] and 40 [30-50] seconds for IM and IN respectively. Time of duration in dorsal recumbency was 59 [53.25-65] and 63 [37-71.25] minutes for IM and IN respectively, without significant differences between treatments. Total time of anesthesia was 88 [86.25-94.5] and 68 [53.5-93] minutes for IM and IN, respectively, with significant difference between groups. The recovery time was lower for IN (15[4.25-19.5] minutes) compared with IM (32 [28.25-38.25] minutes). Two animals of each group presented regurgitation in the recovery period. It was concluded that S+ ketamine and midazolam administered intranasal is an acceptable method of drug delivery and can be used to promote anesthesia in pigeons.(AU)

Benzocaine and clove oil as anesthetics for pejerrey (Odontesthes bonariensis) fingerlings / Benzocaina e óleo de cravo como anestésicos para alevinos de peixe-rei (Odontesthes bonariensis)

Pejerrey (Odontesthes bonariensis) is a native species from Rio Grande do Sul, Uruguay and Argentina where it is of great economic importance for artisanal fishing. One difficulty in laboratory research with pejerrey is related to its sensitivity, as it presents higher basal cortisol levels than other freshwater species. For this reason, the aim of this work was to evaluate the efficiency of benzocaine and clove oil as anesthetics for pejerrey fingerlings. Two experiments were done where fingerlings (57±7.8mm and 1.1±0.44g) were exposed to benzocaine with concentrations between 40mgL-1 and 120mgL-1 and to clove oil with concentrations between 12mgL-1 and 75mgL-1. Survival, anesthesia induction time and recovery time for each pharmaceutics were evaluated. Both benzocaine and clove oil pharmaceutics showed efficiency as anesthetics for pejerrey fingerlings, with negative correlation between the dose of anesthetics and the anesthesia induction time. For benzocaine, the concentrations between 80mgL-1 and 100mgL-1 showed better results, as for clove oil the optimal concentrations were between 25mgL-1 and 50mgL-1. On the other hand, the anesthesia recovery time did not present significant variation on the different concentrations of the tested products. The tested products are highly metabolizable by pejerrey.(AU)

O peixe-rei (Odontesthes bonariensis) é uma espécie nativa do Rio Grande do Sul, Uruguai e Argentina, onde tem grande importância econômica para a pesca artesanal. Uma dificuldade da pesquisa em laboratório com peixe-rei está relacionada à sua sensibilidade, pois apresenta níveis basais de cortisol mais elevados que outras espécies de água doce. Este trabalho avaliou a eficiência da benzocaína e do óleo de cravo como anestésicos para alevinos de peixe-rei. Foram realizados dois experimentos em que alevinos (57±7,08mm e 1,1±0,44g) foram expostos à concentração entre 40mg-1 e 120mgL-1 de benzocaína e entre 12mgL-1 e 75mgL-1 de óleo de cravo. Avaliaram-se a sobrevivência, o tempo de anestesia e o tempo de recuperação para cada um dos fármacos. Ambos os fármacos, benzocaína e óleo de cravo, mostraram eficiência para anestesiar peixe-rei, com correlação negativa entre a dose e o tempo de indução de anestesia. Para benzocaína, concentrações entre 80mgL-1 e 100mgL-1 mostraram melhor resultado, enquanto para óleo de cravo as melhores concentrações ficaram entre 25mgL-1 e 50mgL-1. Por outro lado, o tempo de recuperação do estado de anestesia não apresentou variação significativa nas diferentes concentrações testadas. O peixe-rei tem elevada capacidade de metabolização dos produtos testados.(AU)

Analgesia e anestesia em procedimentos ortopédicos de pequenos animais / Analgesia and anesthesia in small animal orthopedic procedures

A dor é uma experiência sensorial e emocional desagradável que causa alterações fisiológicas no animal, prejudicando a qualidade de vida e prolongando o período de recuperação. Constantemente, os veterinários são desafiados a avaliar e tratar a dor de origem ortopédica. Em muitos casos, a correção cirúrgica da doença ortopédica não é uma opção, assim, um protocolo para anestesia e analgesia perioperatória deve ser cuidadosamente planejado. Em casos de pacientes politraumatizados, a conduta anestésica inclui a avaliação e tratamento do choque e possíveis lesões em outros sistemas. O objetivo do presente trabalho é descrever os principais fármacos e cuidados na anestesia e analgesia de doenças ortopédicas em cães e gatos, destacando o uso de analgésicos e o manejo anestésico desses pacientes.(AU)

Pain is an unpleasant sensory and emotional experience that causes physiological changes in animals, impairing the quality of life and prolonging the recovery period. Veterinarians are constantly challenged to assess and treat pain from orthopedic surgery. In many cases, surgical correction of orthopedic disease is not an option, so a protocol for anesthesia and perioperative analgesia should be carefully planned. In cases of patients with multiple trauma, anesthesia includes the evaluation and treatment of shock and possible injury to other systems. The aim of this paper is to describe the main drugs and care in anesthesia and analgesia for orthopedic diseases in dogs and cats, highlighting the use of analgesics and anesthetic management of these patients.(AU)

Efeitos da infusão contínua de cetamina s(+) em equinos anestesiados pelo halotano / Effects of s(+)-ketamine continuous rate infusion in horses anesthetized by halothane

A manutenção da pressão arterial, no transanestésico, consiste grande desafio, principalmente quando se trata da espécie equina, suscetível à instabilidade cardiovascular. Por isso, torna-se imperioso utilizar técnica anestésica que mantenham estáveis os parâmetros cardiovasculares. A cetamina tem sido amplamente empregada na indução anestésica para o halotano em equinos, conferindo-lhes estabilidade cardiovascular. A cetamina S(+), recentemente disponibilizada no mercado, induz estimulação cardiovascular e possui maior potência anestésica e analgésica em relação à cetamina. Todavia, os efeitos dessa substância, administrada por infusão contínua durante a manutenção da anestesia pelo halotano em equinos, ainda não foram avaliados. Em face da tendência atual de a infusão continuada da cetamina potencializar os anestésicos inalatórios, considerou-se pertinente avaliar os efeitos cardiovasculares e respiratórios desse isômero de cetamina em equinos anestesiados pelo halotano. Conclui-se que a infusão contínua de 0,01mg/kg/min de cetamina S(+) durante anestesia com 1,5 CAM de halotano em equinos não agravou a depressão cardiorrespiratória promovida por esse anestésico inalatório.

The horse’s blood pressure is susceptible to changes induced by volatile anesthetics. Because of that, the use of anesthesic techniques which keep stable the horse´s blood pressure is essencial. Ketamine is an important induction and maintenance anesthetic agent used in the horse anesthesia practice mainly to improve the blood pressure. S(+)-ketamine provides the same effects on the blood pressure, with greater analgesic results and less side effects than the normal ketamine. Although some studies have been conducted with ketamine continuous rate infusion during the halothane anesthetized horses, the S(+)-ketamine has not been evaluated yet. Considering the increased use of ketamine, it is important to evaluate its cardiovascular and respiratory effects in halothane anesthetized horses. To conclude, S(+)-ketamine 0.01mg/kg/min. continuous rate infusion did not induce additive cardiovascular and respiratory depression in halothane anesthetized horses.

Efeitos da infusão contínua de cetamina s(+) em equinos anestesiados pelo halotano / Effects of s(+)-ketamine continuous rate infusion in horses anesthetized by halothane

A manutenção da pressão arterial, no transanestésico, consiste grande desafio, principalmente quando se trata da espécie equina, suscetível à instabilidade cardiovascular. Por isso, torna-se imperioso utilizar técnica anestésica que mantenham estáveis os parâmetros cardiovasculares. A cetamina tem sido amplamente empregada na indução anestésica para o halotano em equinos, conferindo-lhes estabilidade cardiovascular. A cetamina S(+), recentemente disponibilizada no mercado, induz estimulação cardiovascular e possui maior potência anestésica e analgésica em relação à cetamina. Todavia, os efeitos dessa substância, administrada por infusão contínua durante a manutenção da anestesia pelo halotano em equinos, ainda não foram avaliados. Em face da tendência atual de a infusão continuada da cetamina potencializar os anestésicos inalatórios, considerou-se pertinente avaliar os efeitos cardiovasculares e respiratórios desse isômero de cetamina em equinos anestesiados pelo halotano. Conclui-se que a infusão contínua de 0,01mg/kg/min de cetamina S(+) durante anestesia com 1,5 CAM de halotano em equinos não agravou a depressão cardiorrespiratória promovida por esse anestésico inalatório.(AU)

The horses blood pressure is susceptible to changes induced by volatile anesthetics. Because of that, the use of anesthesic techniques which keep stable the horse´s blood pressure is essencial. Ketamine is an important induction and maintenance anesthetic agent used in the horse anesthesia practice mainly to improve the blood pressure. S(+)-ketamine provides the same effects on the blood pressure, with greater analgesic results and less side effects than the normal ketamine. Although some studies have been conducted with ketamine continuous rate infusion during the halothane anesthetized horses, the S(+)-ketamine has not been evaluated yet. Considering the increased use of ketamine, it is important to evaluate its cardiovascular and respiratory effects in halothane anesthetized horses. To conclude, S(+)-ketamine 0.01mg/kg/min. continuous rate infusion did not induce additive cardiovascular and respiratory depression in halothane anesthetized horses.(AU)

Efeitos cardiovasculares da anestesia dissociativa na reposição volêmica com colóide e solução hipertônica em cães: avaliação biotelemétrica / Cardiovascular effects of dissociative anesthesia in the volemic expansion with colloid and hypertonic solution in dogs: biotelemetric evaluation

Avaliaram-se os efeitos cardiovasculares por um período de 24 horas, após a administração de solução salina hipertônica (NaCl) 7,5 por cento ou em associação ao hidroxietilamido 130/0,4 (HES), em cães com hipovolemia induzida e tratados com cetamina levógira ou racêmica. Após a indução da hipovolemia, administrou-se NaCl 7,5 por cento (4mL/kg) no grupo hipertônica levógira (GHL) e no grupo hipertônica racêmica (GHR) ou HES 130/0,4 na mesma proporção de sangue retirado, associado a NaCl 7,5 por cento (4mL/kg) no grupo hipertônica colóide levógira (GHCL) e no grupo hipertônica colóide racêmica (GHCR). Após 30 minutos, administrou-se por via intravenosa, cetamina levógira (CL; 5mg/kg) no GHL e GHCL ou cetamina racêmica (CR; 10mg/kg) no GHR e GHCR. A frequência cardíaca (FC) e a pressão arterial sistólica (PAS) foram menores após a hipovolemia e após a CR. A pressão arterial média (PAM) e a pressão arterial diastólica (PAD) foram menores após a hipovolemia e após a administração de CL e CR. Não foram observadas diferenças significativas entre os grupos em relação à FC, PAS, PAM e PAD durante o período de mensuração por biotelemetria desde T210 até T1440. A administração de HES associado ao NaCl 7,5 por cento propiciou restabelecimento imediato da PAM, a administração de NaCl 7,5 por cento não restaurou a PAM em pacientes hipovolêmicos, a administração de CR ou CL produziu efeitos semelhantes e todos os tratamentos mantiveram estáveis as pressões arteriais e a FC por um período de até 24 horas.(AU)

The cardiovascular effects were evaluated for a 24-hour period, after the administration of hypertonic solution (NaCl 7.5 percent) or in association with hidroxyethyl starch 130/0.4 (HES) in dogs under induced experimental hypovolemia and treated with racemic ketamine (RK) or S(+) ketamine (SK). After the hypovolemia induction, administration of NaCl 7.5 percent (4mL.kg-1) was performed in two groups named hypertonic S(+) (HSG) and hypertonic racemic (HRG), or NaCl 7.5 percent (4mL.kg-1) in association with HES, in the same ratio of removed blood, in two groups named hypertonic colloid S(+) (HCSG) and hypertonic colloid racemic (HCRG). After 30 minutes, SK (5mg.kg-1) was administered by intravenous injection in HSG and HCSG groups, or RK (10mg.kg-1) in HRG and HCRG groups. The heart rate (HR) and systolic arterial pressure (SAP) were lower after hypovolemia and RK. Mean (MAP) and diastolic arterial pressure (DAP) were reduced after hypovolemia and either SK or RK administration. Significant differences were not observed among the groups to HR, SAP, MAP, and DAP during the biotelemetry mensuration period, from T210 to T1440. HES associated with NaCl 7.5 percent administration propitiated immediate re-establishment of MAP. NaCl 7.5 percent administration did not restore MAP in hypovolemic patients. Either RK or SK administrations produced similar effects and all of the treatments maintained stable blood pressure and heart rate for a 24-hour period.(AU)

Anestesia em cães cardiopatas / Anesthesia in dogs heart

O conhecimento dos efeitos cardiovasculares dos diversos anestésicos utilizados rotineiramente em cães é de extrema importância, uma vez que a incidência de procedimentos que necessitam de anestesia em animais portadores de cardiopatias é crescente atualmente. Dentre as cardiopatias mais freqüentemente diagnostica das em cães estão a insuficiência de válvula mitral e a cardiomiopatia dilatada, sendo respectivamente mais comuns em cães de raças de pequeno e de grande porte. Estas alterações cardíacas provocam importantes distúrbios hemodinâmicos que podem ser intensificados com o uso inadequado de alguns fármacos. Devido a isto, a escolha adequada de anestésicos para a medicação pré-anestésica, indução e manutenção da anestesia se torna imprescindível(AU)

The knowledge of cardiovascular effects of different anesthesics drugs used in dogs is important since the incidence of procedures requiring anesthesia in animals suffering from heart diseases is growing nowadays. Among the most commonly diagnosed heart diseases in dogs are mitral valve failure and dilated cardiomyopathy, respectively being more common in small and large breed dogs. These cardiac changes cause significant hemodynamic disturbances that may be intensified with the inappropriate use of some anesthesics drugs. Concluding, the correct choice of anesthesics drugs to preanesthetic induction and maintenance of anesthesia becomes essential(AU)

Anestesia em cães cardiopatas / Anesthesia in dogs heart

O conhecimento dos efeitos cardiovasculares dos diversos anestésicos utilizados rotineiramente em cães é de extrema importância, uma vez que a incidência de procedimentos que necessitam de anestesia em animais portadores de cardiopatias é crescente atualmente. Dentre as cardiopatias mais freqüentemente diagnostica das em cães estão a insuficiência de válvula mitral e a cardiomiopatia dilatada, sendo respectivamente mais comuns em cães de raças de pequeno e de grande porte. Estas alterações cardíacas provocam importantes distúrbios hemodinâmicos que podem ser intensificados com o uso inadequado de alguns fármacos. Devido a isto, a escolha adequada de anestésicos para a medicação pré-anestésica, indução e manutenção da anestesia se torna imprescindível

The knowledge of cardiovascular effects of different anesthesics drugs used in dogs is important since the incidence of procedures requiring anesthesia in animals suffering from heart diseases is growing nowadays. Among the most commonly diagnosed heart diseases in dogs are mitral valve failure and dilated cardiomyopathy, respectively being more common in small and large breed dogs. These cardiac changes cause significant hemodynamic disturbances that may be intensified with the inappropriate use of some anesthesics drugs. Concluding, the correct choice of anesthesics drugs to preanesthetic induction and maintenance of anesthesia becomes essential